The latest at MBC Biolabs
The latest at MBC Biolabs
Neopeutics Wins 2015 North America Frost & Sullivan Award for Technology Leadership
Based on its recent analysis of the enhanced drug discovery market, Frost & Sullivan recogniz [...]
Symic Adds Expertise to its Board
Symic Biomedical announced today the appointment of Barbara Yanni and William J. Newell to its bo [...]
Amarantus to Present Positive Alzheimer’s Disease Biomarker Data
Amarantus announced that its abstract titled "The LymPro® Assay: A Biomarker For Alzheimer's Dise [...]
MedGenome to Raise $15M in Second Round of Funding
MedGenome, backed by Mu Sigma co-founders Dhiraj Rajaram and Ambiga Dhiraj, is looking to raise $ [...]
Amarantus Inks Alzheimer’s Biomarker Test Deal with Anavex
Amarantus BioScience Holdings today said that it has signed a deal to provide biomarker test serv [...]
Senior Management Changes at Assembly Biosciences
Co-founder Derek Small succeeds Russell H. Ellison, MD, as CEO, as had been agreed in the merger [...]
John Mulcahy, SiteOne Therapeutics
Developing a non-addictive painkiller to compete with opiates Mission Bay Capital portfolio comp [...]
Colleen Cutcliffe, Whole Biome
Improving human health by sequencing and analyzing the microbiome and developing targeted therapi [...]
Uri Lopatin, Assembly Biosciences
Targeting the hepatitis B virus Ramen to reverse merger in under two years. Uri Lopatin co-founde [...]
MedGenome keen to team-up with state govts
MedGenome is looking to partner with the state governments in the country to offer its OncoMD, a [...]
Innovation in fixed-dose combos: HIV/AIDS therapeutics edition
The FDA has published guidance to support the submission process for companies developing fixed-d [...]
It’s free! QB3 inks equipment donation deal for biomed startups
One of the lures of the University of California's QB3 incubator network for life sciences startu [...]